Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Pancreatic Ductal Adenocarcinoma × Ropivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 6 Breast Neoplasms 5 Prostatic Neoplasms 4 Lung Neoplasms 3 Stomach Neoplasms 2 Pain 2 Neoplasms 2 Agnosia 2 Supratentorial Neoplasms 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pain, Intractable 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Meningioma 1 Liver Neoplasms 1 Liver Diseases 1 Kidney Neoplasms 1 Ganglion Cysts 1 Esophageal Neoplasms 1 Emergence Delirium 1 ENT Cancers 1 Cystic Adenomatoid Malformation of Lung, Congenital 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carpal Tunnel Syndrome 1 Cancer Pain 1 Bronchopulmonary Sequestration 1

Interventions

sonidegib 1 glucoraphanin 1 Transurethral Resection of Prostate 1 Tissue Banks 1 Specimen Handling 1 Saline Solution 1 Ropivacaine 1 Robotic Surgical Procedures 1 Pancreaticoduodenectomy 1 Glucose 1 Genetic Testing 1 Electroporation 1 Drug Therapy 1 Conversion to Open Surgery 1 Contrast Media 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06214533 2024-01-19

CEBOIDS

Sixth Affiliated Hospital, Sun Yat-sen University

Phase NA Unknown

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡